furosemide has been researched along with Cochlear Diseases in 8 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Cochlear Diseases: Pathological processes of the snail-like structure (COCHLEA) of the inner ear (LABYRINTH) which can involve its nervous tissue, blood vessels, or fluid (ENDOLYMPH).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aminoglycoside antibiotics are highly effective agents against gram-negative bacterial infections, but they cause adverse effects on hearing and balance dysfunction as a result of toxicity to hair cells of the cochlea and vestibular organs." | 5.40 | Systemic lipopolysaccharide induces cochlear inflammation and exacerbates the synergistic ototoxicity of kanamycin and furosemide. ( Hirose, K; Li, SZ; Ohlemiller, KK; Ransohoff, RM, 2014) |
| "Furosemide is a loop diuretic which is ototoxic." | 5.28 | Effects of organic acids on the edema of the stria vascularis induced by furosemide. ( Rybak, LP; Scott, V; Weberg, A; Whitworth, C, 1992) |
| "ECochG and glycerol and furosemide tests were performed in 1569 patients with various cochleovestibular diseases, including definite MD, atypical MD, syphilitic labyrinthitis, delayed endolymphatic hydrops, sudden hearing loss, cochleovestibulopathy and sensorineural hearing loss." | 3.72 | Prediction of progression from atypical to definite Ménière's disease using electrocochleography and glycerol and furosemide tests. ( Aso, S; Kimura, H; Watanabe, Y, 2003) |
| "Aminoglycoside antibiotics are highly effective agents against gram-negative bacterial infections, but they cause adverse effects on hearing and balance dysfunction as a result of toxicity to hair cells of the cochlea and vestibular organs." | 1.40 | Systemic lipopolysaccharide induces cochlear inflammation and exacerbates the synergistic ototoxicity of kanamycin and furosemide. ( Hirose, K; Li, SZ; Ohlemiller, KK; Ransohoff, RM, 2014) |
| "Furosemide is a loop diuretic which is ototoxic." | 1.28 | Effects of organic acids on the edema of the stria vascularis induced by furosemide. ( Rybak, LP; Scott, V; Weberg, A; Whitworth, C, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Košec, A | 1 |
| Kruljac, I | 1 |
| Ajduk, J | 1 |
| Kraft, S | 1 |
| Hsu, C | 1 |
| Brough, DE | 1 |
| Staecker, H | 1 |
| Schmitz, HM | 1 |
| Johnson, SB | 1 |
| Santi, PA | 1 |
| Hirose, K | 1 |
| Li, SZ | 1 |
| Ohlemiller, KK | 1 |
| Ransohoff, RM | 1 |
| Kimura, H | 1 |
| Aso, S | 1 |
| Watanabe, Y | 1 |
| Oesterle, EC | 1 |
| Campbell, S | 1 |
| Taylor, RR | 1 |
| Forge, A | 1 |
| Hume, CR | 1 |
| Rybak, LP | 1 |
| Whitworth, C | 1 |
| Weberg, A | 1 |
| Scott, V | 1 |
| Ito, Z | 1 |
| Kusakari, J | 1 |
| Takeyama, M | 1 |
| Nishikawa, N | 1 |
| Hara, A | 1 |
| Nakata, H | 1 |
8 other studies available for furosemide and Cochlear Diseases
| Article | Year |
|---|---|
Remission of Recurrent Cochlear Hydrops Associated With Bromocriptine Treatment for Macroprolactinoma.
Topics: Adult; Audiometry, Pure-Tone; Bromocriptine; Cochlear Diseases; Diuretics; Furosemide; Glucocorticoi | 2019 |
Atoh1 induces auditory hair cell recovery in mice after ototoxic injury.
Topics: Animals; Anti-Bacterial Agents; Basic Helix-Loop-Helix Transcription Factors; Cochlear Diseases; Diu | 2013 |
Kanamycin-furosemide ototoxicity in the mouse cochlea: a 3-dimensional analysis.
Topics: Animals; Cochlea; Cochlear Diseases; Disease Models, Animal; Female; Furosemide; Hair Cells, Auditor | 2014 |
Systemic lipopolysaccharide induces cochlear inflammation and exacerbates the synergistic ototoxicity of kanamycin and furosemide.
Topics: Animals; Anti-Bacterial Agents; Cochlea; Cochlear Diseases; CX3C Chemokine Receptor 1; Disease Model | 2014 |
Prediction of progression from atypical to definite Ménière's disease using electrocochleography and glycerol and furosemide tests.
Topics: Adolescent; Adult; Aged; Audiometry, Evoked Response; Child; Cochlear Diseases; Disease Progression; | 2003 |
Sox2 and JAGGED1 expression in normal and drug-damaged adult mouse inner ear.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Biomarkers; Calcium-Binding Proteins; Chickens; Co | 2008 |
Effects of organic acids on the edema of the stria vascularis induced by furosemide.
Topics: Acids; Animals; Cochlear Diseases; Edema; Evoked Potentials, Auditory; Furosemide; Microscopy, Elect | 1992 |
The effect of furosemide on the endocochlear potential in ears with experimentally induced endolymphatic hydrops.
Topics: Animals; Cochlea; Cochlear Diseases; Edema; Endolymphatic Duct; Evoked Potentials; Furosemide; Guine | 1991 |